Skip to main content
. 2019 Jun 20;4(12):e125377. doi: 10.1172/jci.insight.125377

Table 2. Summary of adverse events that occurred in patients randomized to receive palifermin (n = 14) versus placebo (n = 14).

graphic file with name jciinsight-4-125377-g182.jpg